The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 05, 2023
Filed:
Jun. 23, 2017
Applicant:
Saint Louis University, St. Louis, MO (US);
Inventors:
Thomas Burris, Columbia, MO (US);
John K. Walker, St. Louis, MO (US);
Colin Flaveny, St. Louis, MO (US);
Arindam Chatterjee, St. Louis, MO (US);
Assignee:
Saint Louis University, Saint Louis, MO (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 401/04 (2006.01); C07D 217/26 (2006.01); C07D 401/12 (2006.01); C07D 217/06 (2006.01); C07D 417/04 (2006.01); C07D 409/04 (2006.01); C07D 215/38 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
C07D 401/04 (2013.01); C07D 215/38 (2013.01); C07D 217/06 (2013.01); C07D 217/26 (2013.01); C07D 401/12 (2013.01); C07D 409/04 (2013.01); C07D 417/04 (2013.01); A61K 9/0019 (2013.01); A61K 9/0053 (2013.01);
Abstract
In some aspects, the present disclosure provides compounds of the formula: (I) or (II) wherein the variables are as defined herein. In some embodiments, these compounds may be used to treat cancer or other hyperproliferative diseases, as well as atherosclerosis and coronary artery disease.
Burris, Thomas. (2023). Lxr inverse agonists for treatment of cancer (U.S. Patent No. 11746097). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11746097
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile